Medical imaging for improved tumour characterization, delineation and treatment verification

Acta Oncologica

Volumn 41, Issue 7-8, 2002, Pages 604-614

  Forssell Aronsson, Eva ^a   Kjellén, Elisabeth ^b   Mattsson, Sören ^b   Hellström, Mikael ^a   Brahme, Anders ^c   Carlsson, Jörgen ^c   Glimelius, Bengt ^c   Johansson, Karl Axel ^c   Littbrand, Bo ^c   Nordenskjöld, Bo ^c   Stenerlöw, Bo ^c   Turesson, Ingela ^c   Zackrisson, Björn ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; RADIOTHERAPY; RESEARCH; TUMORS;

DELINEATION;

MEDICAL IMAGING;

ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STAGING; EVALUATION; FOLLOW UP; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SWEDEN; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 12244259066     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418602321028201     Document Type: Article

References (26)

1. Alexander A, Nazarian L, Feld R. Superficial soft tissue masses suggestive of recurrent malignancy: sonographic localization and biopsy. Am J Roentgenol 1997; 169: 1449-51.
2. Zakian KL, Koutcher JA, Ballon D, et al. Developments in nuclear magnetic resonance imaging and spectroscopy: application to radiation oncology. Semin Radiat Oncol 2001; 11: 3-15.
3. De Schepper AM, De Beuckeleer L, Vandevenne J, et al. Magnetic resonance imaging of soft tissue tumors. Eur Radiol 2000; 10: 213-22.
4. Krishnan L, Krishnan EC, Jewell WR. Immediate effect of irradiation on microvasculature. Int J Radiat Oncol Biol Phys 1988; 15: 147-50.
5. Neeman M, Provenzale JM, MW D. Magnetic resonance imaging applications in the evaluation of tumor angiogensis. Semin Radiat Oncol 2001; 11: 70-82.
6. Rosenman J. Incorporating functional imaging information into radiation treatment. Semin Radiat Oncol 2001; 11: 83-92.
7. Vanel D, Shapeero L, Guinebretière J, et al. Posttreatment assessment of soft tissue tumours. In: De Schepper A, ed. Imaging of soft tissue tumors. Berlin, Heidelberg, New York: Springer-Verlag, 1997: 113-26.
8. Vanel D, Shapeero L, Tardivon A, et al. Dynamic contrast-enhanced MRI with subtraction of aggressive soft tissue tumors after resection. Skeletal Radiol 1998; 27: 505-10.
9. Kim EE, Yang D J, eds. Targeted molecular imaging in oncology. New York: Springer-Verlag; 2001.
10. Kalofonos HP, Karamouzis MV, Epenetos AA. Radioimmunoscintigraphy in patients with ovarian cancer. Acta Oncol 2001; 40: 549-57.
11. Chapman JD, Schneider RF, Urbain JL, et al. Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation. Semin Radiat Oncol 2001; 11: 47-57.
12. Mankoff DA, Bellon JR. Positron-emission tomographic imaging of cancer: glucose metabolism and beyond. Semin Radiat Oncol 2001; 11: 16-27.
13. Gambhir SS, Herschman HR, Cherry SR, et al. Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2000; 2: 118-38.
14. Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42: 1S-93S.
15. Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002; 62: 51-60.
16. Mah K, Caldwell CB, Ung YC, et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2002; 52: 339-50.
17. Zinzani P, Magagnoli M, Chierichetti F, et al. The role of positron emission tomography (PET) in the management of lymphoma patients. Ann Oncol 1999; 10: 1181-4.
18. Mansel RE, Khonji NI, DC. History, present status and future of sentinel node biopsy in breast cancer. The Mary Beves Lecture. Acta Oncol 2000; 39: 265-8.
19. Langmack KA. Portal imaging. Br J Radiol 2001; 74: 789-804.
20. Autolak JA, Rosen II. Planning target volumes for radiotherapy: how much margin is needed? Int J Radiat Oncol Biol Phys 1999; 44: 1165-70.
21. Giraud P, Elles S, Helfre S, et al. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 2002; 62: 27-36.
22. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001; 51: 880-914.
23. Tubiana M, Eschwege F. Conformal radiotherapy and intensity-modulated radiotherapy - clinical data. Acta Oncol 2000; 39: 555-67.
24. WHO. Handbook for reporting results of cancer treatment. WHO offset publication no 48. Geneva, 1979.
25. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205-16.
26. Padani AR, Husband JE. Are current tumour response criteria relevant for the 21st century? Br J Radiol 2000; 73: 1031-3.